← Study Library
RCT · 2007
Promisingcounts toward this tierVitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7
Schurgers LJ, Teunissen KJ, Hamulyák K, et al. · Blood
Promisingcounts toward this tier
The pharmacokinetic case for taking K2 rather than K1: both forms were absorbed well and peaked in serum at 4 hours, but MK-7 has a far longer half-life, giving much more stable serum levels and 7- to 8-fold higher accumulation during prolonged intake, and it carboxylated osteocalcin more completely. The authors warn that 50 ug/day or more of MK-7 can interfere with oral anticoagulant treatment.
- Population
- Healthy volunteers given single and prolonged oral doses
- Intervention
- Synthetic vitamin K1 (phylloquinone) versus natto-derived menaquinone-7
- Comparator
- K1 against MK-7, head to head
- Limitations
- Small mechanistic trial in healthy volunteers with blood markers as endpoints; full text paywalled, so this record is appraised from the paper's published summary; nothing measured in bone, artery or joint outcomes.
Cited by
1 entry references this study
- Vitamin K2 (MK-7)PROM.
Supplements → Vitamins & cofactors · key study